.
PIDILITIND financial statements
* Numbers in billions
| Capitalization * | 1 188 |
|---|---|
| EV * | 922 |
| Number of shares * | 1 |
| EPS | 22,26 |
| Revenue * | 73 |
| Net income * | 11 |
| Operating profit * | 15 |
| Total liabilities * | 30 |
| Net debt * | -1 |
| Total assets * | 88 |
| Equity * | 56 |
| Cash and investments * | 6 |
.
PIDILITIND valuation
| P/E | 105,03 |
|---|---|
| P/B | 21,24 |
| P/S | 16,39 |
| E/P | 1 |
| P/FCF | 114,42 |
.
PIDILITIND profitability
| ROE | 20% |
|---|---|
| ROA% | 19% |
| ROIC% | 23% |